Institution
École normale supérieure de Cachan
Education•Cachan, Île-de-France, France•
About: École normale supérieure de Cachan is a education organization based out in Cachan, Île-de-France, France. It is known for research contribution in the topics: Decidability & Nonlinear system. The organization has 2717 authors who have published 5585 publications receiving 175925 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Comparison and global existence results for solutions of coupled matrix Riccati differential equations appearing in closed loop Nash games and in mixed H/sub 2//H/sub /spl infin//-type problems are presented.
Abstract: Presents comparison and global existence results for solutions of coupled matrix Riccati differential equations appearing in closed loop Nash games and in mixed H/sub 2//H/sub /spl infin//-type problems. Convergence of solutions is established for the diagonal case, solutions of the corresponding algebraic equations are discussed using numerical examples.
119 citations
••
TL;DR: It is confirmed that expeditious and reproducible bilayer formation is realized by control of the composition of the solvent, a mixture of n-decane and 1-hexanol, which permits simultaneous incorporation of the alpha-hemolysin nanopores to the membrane array.
Abstract: We present a microarray system that enables simultaneous monitoring of multiple ionic currents through transmembrane α-hemolysin nanopores arrayed at bilayer lipid membranes. We applied the self-assembling ability of lipid molecules interfaced between an aqueous solution and organic solvent to induce bilayer membrane formation at a microfluidic device; the device consists of a hydrophobic polymer film that serves to suspend the lipid-containing solvent at micrometer-sized apertures as well as to separate the aqueous solution into two chambers. In this study, we confirmed that expeditious and reproducible bilayer formation is realized by control of the composition of the solvent, a mixture of n-decane and 1-hexanol, which permits simultaneous incorporation of the α-hemolysin nanopores to the membrane array. Monitoring the eight wells on the array at once, we obtained a maximum of four relevant, synchronous signals of translocating ionic current through the nanopores. The system was also able to detect tran...
119 citations
••
TL;DR: The microchip advantages, high surface/volume ratio, and dynamic loadings, coupled with the concordance between the present and literature results dealing with ammonia/ammonium effects on MDCK illustrate the potential of the microchip for wider in vitro chronic toxicity investigations.
Abstract: Current developments in tissue engineering and microtechnology fields have allowed the proposal of pertinent tools, microchips, to investigate in vitro toxicity. In the framework of the proposed REACH European directive and the 3R recommendations, the purpose of these microtools is to mimic organs in vitro to refine in vitro culture models and to ultimately reduce animal testing. The microchip consists of functional living cell microchambers interconnected by a microfluidic network that allows continuous cell feeding and waste removal controls by fluid microflow. To validate this approach, Madin Darby Canine Kidney (MDCK) cells were cultivated inside a polydimethylsiloxane microchip. To assess the cell proliferation and feeding, the number of inoculated cells varied from 5 to 10 x 10(5) cells/microchip (corresponding roughly to 2.5 to 5 x 10(5) cells/cm2) and from four flow rates 0, 10, 25, and 50 microL/min were tested. Morphological observations have shown successful cell attachment and proliferation inside the microchips. The best flow rate appears to be 10 microL/min with which the cell population was multiplied by about 2.2 +/- 0.1 after 4 days of culture, including 3 days of perfusion (in comparison to 1.7 +/- 0.2 at 25 microL/min). At 10 microL/min flow rate, maximal cell population reached about 2.1 +/- 0.2 x 10(6) (corresponding to 7 +/- 0.7 x 10(7) cells/cm(3)). The viability, assessed by trypan blue and lactate deshydrogenase measurements, was found to be above 90% in all experiments. At 10 microL/min, glucose monitoring indicated a cell consumption of 16 +/- 2 microg/h/10(6) cells, whereas the glutamine metabolism was demonstrated with the production of NH3 by the cells about 0.8 +/- 0.4 micromol/day/10(6) cells. Augmentation of the flow rate appeared to increase the glucose consumption and the NH3 production by about 1.5- to 2-fold, in agreement with the tendencies reported in the literature. As a basic chronic toxicity assessment in the microchips, 5 mM and 10 mM ammonium chloride loadings, supplemented in the culture media, at 0, 10, and 25 micaroL/min flow rates were performed. At 10 microL/min, a reduction of 35% of the growth ratio with 5 mM and of 50% at 10 mM was found, whereas at 25 microL/min, a reduction of 10% with 5 mM and of 30% at 10 mM was obtained. Ammonium chloride contributed to increase the glucose consumption and to reduce the NH3 production. The microchip advantages, high surface/volume ratio, and dynamic loadings, coupled with the concordance between the present and literature results dealing with ammonia/ammonium effects on MDCK illustrate the potential of our microchip for wider in vitro chronic toxicity investigations.
118 citations
••
TL;DR: In this article, the authors address several issues pertaining to efficiency of the computational approach geared towards modeling of inelastic behavior of a heterogeneous structure, which is represented by a multi-scale model.
118 citations
••
Rafael Advanced Defense Systems1, Montreal Neurological Institute and Hospital2, University of Turin3, Carlos III Health Institute4, Autonomous University of Barcelona5, Beth Israel Deaconess Medical Center6, École normale supérieure de Cachan7, Aix-Marseille University8, Necker-Enfants Malades Hospital9
TL;DR: Results show that masitinib at 4.5 mg/kg/d can benefit patients with ALS and a confirmatory phase 3 study will be initiated to substantiate these data.
Abstract: Objective: To assess masitinib in the treatment of ALS. Methods: Double-blind study, randomly assigning 394 patients (1:1:1) to receive riluzole (100 mg/d) plus placebo or masitinib at 4.5 or 3.0 m...
118 citations
Authors
Showing all 2722 results
Name | H-index | Papers | Citations |
---|---|---|---|
Shi Xue Dou | 122 | 2028 | 74031 |
Olivier Hermine | 111 | 1026 | 43779 |
John R. Reynolds | 105 | 607 | 50027 |
Shaul Mukamel | 95 | 1030 | 40478 |
Tomás Torres | 88 | 625 | 28223 |
Ifor D. W. Samuel | 74 | 605 | 23151 |
Serge Abiteboul | 73 | 278 | 24576 |
Stéphane Roux | 68 | 627 | 19123 |
Zeger Debyser | 67 | 404 | 16531 |
Louis Nadjo | 64 | 264 | 12596 |
Praveen K. Thallapally | 64 | 190 | 12110 |
Andrew Travers | 63 | 193 | 13537 |
Shoji Takeuchi | 63 | 692 | 14704 |
Bineta Keita | 63 | 274 | 12053 |
Yves Mély | 62 | 368 | 13478 |